Prolight Diagnostics AB (LTS:0G5I) FCF Margin %: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0G5I Prolight Diagnostics AB LTS:0G5I
31 GF Score
Price kr15.70
! 1 Warning Sign
View Full Analysis

What is Prolight Diagnostics AB FCF Margin %?

Prolight Diagnostics AB LTS:0G5I 31 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates LTS:0G5I with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 816 Medical Devices & Instruments companies, Prolight Diagnostics AB ranks worse than 122548.9% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Prolight Diagnostics AB's Free Cash Flow for the three months ended in Mar. 2026 was kr-23.45 Mil. Prolight Diagnostics AB's Revenue for the three months ended in Mar. 2026 was kr0.00 Mil. Therefore, Prolight Diagnostics AB's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Prolight Diagnostics AB's current FCF Yield % is -31.33%.

The historical rank and industry rank for Prolight Diagnostics AB's FCF Margin % or its related term are showing as below:


LTS:0G5I's FCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -0.56
* Ranked among companies with meaningful FCF Margin % only.

Prolight Diagnostics AB FCF Margin % Related Terms

Prolight Diagnostics AB FCF Margin % Historical Data

* Premium members only.

The historical data trend for Prolight Diagnostics AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prolight Diagnostics AB FCF Margin % Chart

Prolight Diagnostics AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Prolight Diagnostics AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

LTS:0G5I vs ISRG, BDX, MDLN: FCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, Prolight Diagnostics AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prolight Diagnostics AB FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Prolight Diagnostics AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Prolight Diagnostics AB's FCF Margin % falls into.


LTS:0G5I
31GF Score
Prolight Diagnostics AB LTS:0G5I
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prolight Diagnostics AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Prolight Diagnostics AB's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-56.735/0
= %

Prolight Diagnostics AB's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-23.445/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Prolight Diagnostics AB (LTS:0G5I) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Prolight Diagnostics AB and its competitors. According to the industry distribution chart, Prolight Diagnostics AB ranks #999999 out of 816 companies in the Medical Devices & Instruments industry.
Is Prolight Diagnostics AB's FCF Margin % too high?
Prolight Diagnostics AB's current FCF Margin % is 0.00%. Based on the distribution chart, Prolight Diagnostics AB ranks #999999 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Prolight Diagnostics AB has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Prolight Diagnostics AB's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Prolight Diagnostics AB ranks #999999 out of 816 companies for FCF Margin %. This places Prolight Diagnostics AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Prolight Diagnostics AB and its competitors. Prolight Diagnostics AB's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prolight Diagnostics AB stock overvalued right now?
Prolight Diagnostics AB (LTS:0G5I) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Prolight Diagnostics AB's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Prolight Diagnostics AB (LTS:0G5I), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Prolight Diagnostics AB Business Description

Other Exchanges PRLD:Sweden
Address Gasverksgatan 3A, Lund, SWE, 222 29
Prolight Diagnostics AB along with its subsidiaries, develops Point-of-Care (POC) systems, which are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. Its product portfolio includes Psyros, a digital POC technology, and Microflex.
31GF Score

Get the complete analysis for LTS:0G5I

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr15.70
Price